8-KItem 5.02 · Officer/Director ChangeItem 9.01 · Financial Statements
Mark Bezjak informed Zimmer Biomet on Jan 8, 2026 he will resign employment and all officer positions…
Filed with the SEC on · Summarized by InvestorsBot
Mark Bezjak informed Zimmer Biomet on Jan 8, 2026 he will resign employment and all officer positions effective Jan 16, 2026 to pursue another business opportunity. He was a named exec in the 2025 proxy and ceased being an exec officer on Jul 1, 2025. $ZBH 📅➡️ #Leadership #SECfiling
Item 5.02 reports Bezjak’s resignation; no successor or additional compensatory arrangements are named in this filing. This completes his employment exit timeline after ceasing to be an executive officer on Jul 1, 2025. Monitor future disclosures. $ZBH 🔎🧾 #InvestorAlert #CorporateGovernance